Loading
株式会社PRISM BioLab Stock: price and insider trades · Japan
JP·Mcap JP¥5.1B
株式会社PRISM BioLab: what insiders have been doing
株式会社PRISM BioLab is a listed company. Its insiders report their share dealings to EDINET (Japan FSA). Over the twelve months to 25 October 2026, 6 filings were filed, from 3 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 3,423 companies) published 3 filings over the same period, against 6 filings here.
Over the last twelve months, not one insider purchase of 株式会社PRISM BioLab stock was filed. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. Until a filing is published, the market cannot know about the trade.
This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Insider Decl.
19
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,607 of 26,291 companies
22.0
score / 100
Value9
Quality35
FCF yld-30%
Earn yld-16%
EV/EBITDA·
ROE-38%
Gross mgn40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
JP¥138
Analyst consensus
Income statement
RevenueJP¥677.3M
Gross profitJP¥269.8M40% margin
EBITDA-JP¥774.5M-114% margin
Net income-JP¥833.7M-118.7% margin
Valuation
P/Book2.7x
Beta1.40
Balance sheet & cash
Market capJP¥5.1B
Free Cash Flow-JP¥1.5B
Profitability & ownership
ROE-37.9%
ROA-17.9%
% insiders36.1%
% institutions24.0%
Last declaration on 6 October 2026
Declarations19 total
ShareXTKSEDINET:S100Z5Y7
ShareXTKSEDINET:S100YTU1
ShareXTKSEDINET:S100YOTD
49.0% of flowShareXTKSEDINET:S100X952
21.5% of flowShareXTKSEDINET:S100X95F
29.2% of flowShareXTKSEDINET:S100X956
ShareXTKSEDINET:S100UV9J
ShareXTKSEDINET:S100UJ39
ShareXTKSEDINET:S100UJ7L
ShareXTKSEDINET:S100UHMQ
0.1% of flowShareXTKSEDINET:S100U0LE
49.3% of flowShareXTKSEDINET:S100U0NO
0.1% of flowShareXTKSEDINET:S100U0N8
100.0% of flowShareXTKSEDINET:S100TMNJ
100.0% of flowShareXTKSEDINET:S100TXEX
51.0% of flowShareXTKSEDINET:S100TL5L
99.9% of flowShareXTKSEDINET:S100TZIS
99.9% of flowShareXTKSEDINET:S100TYI6
100.0% of flowShareXTKSEDINET:S100TZ4M
19 of 19 declarations
About 株式会社PRISM BioLab
PRISM BioLab is a Japanese company listed on the XTKS market, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the biotechnology sector.
